University of Pennsylvania Study Finds a Surprising Link Between Ozempic and Breast Cancer Risk

Researchers at the University of Pennsylvania found a striking link between Ozempic and breast cancer risk—but it’s not yet clear what’s driving it.

Women taking GLP-1 medications like Ozempic and Wegovy were roughly 30 percent less likely to develop breast cancer than women who weren’t, according to a new study from the University of Pennsylvania.

The findings, presented at the 2026 American Society of Clinical Oncology Annual Meeting, are drawing attention in........

© Inc.com